1
|
Hogarth KA, Shkumat NA, Goman S, Amirabadi A, Bickford S, Muthusami P, Connolly BL, Maynes JT. Biomarkers of mitochondrial stress and DNA damage during pediatric catheter-directed neuroangiography - a prospective single-center study. Pediatr Radiol 2024; 54:1906-1918. [PMID: 39285018 DOI: 10.1007/s00247-024-06048-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/02/2024] [Revised: 08/21/2024] [Accepted: 08/25/2024] [Indexed: 10/15/2024]
Abstract
BACKGROUND Neuroangiography represents a critical diagnostic and therapeutic imaging modality whose associated radiation may be of concern in children. The availability of in vivo radiation damage markers would represent a key advancement for understanding radiation effects and aid in the development of radioprotective strategies. OBJECTIVE Determine if biomarkers of cellular damage can be detected in the peripheral blood mononuclear cells (PBMC) of children undergoing neuroangiography. MATERIALS AND METHODS Prospective single-site study of 27 children. Blood collected pre and post neuroangiography, from which PBMC were isolated and assayed for biomarkers of mitochondrial stress (mitochondrial membrane potential (MMP), reactive oxygen species (ROS), and mitochondrial DNA (mtDNA)) and DNA damage (γH2AX). Dose response of biomarkers vs. radiation dose was analyzed using linear regressions. The cohort was divided into higher (HD) and lower dose (LD) groups and analyzed using linear mixed models and compared using Welch's t-tests. RESULTS No biomarker exhibited a dose-dependent response following radiation (γH2AX: R2 = 0.0012, P = 0.86; MMP: R2 = 0.016, P = 0.53; mtDNA: R2 = 0.10, P = 0.11; ROS: R2 = 0.0023, P = 0.81). Groupwise comparisons showed no significant differences in γH2AX or ROS after radiation (γH2AX: LD: 0.6 ± 6.0, P = 0.92; HD: -7.5 ± 6.3 AU, P = 0.24; ROS: LD: 1.3 ± 2.8, P = 0.64; HD: -3.6 ± 3.0 AU, P = 0.24). Significant changes were observed to mitochondrial markers MMP (-53.7 ± 14.7 AU, P = 0.0014) and mtDNA (-1.1 ± 0.4 AU, P = 0.0092) for HD, but not the LD group (MMP: 26.1 ± 14.7 AU, P = 0.090; mtDNA: 0.2 ± 0.4, P = 0.65). CONCLUSIONS Biomarkers of mitochondrial stress in PBMC were identified during pediatric neuroangiography and warrant further investigation for radiation biodosimetry. However, isolating radiation-specific effects from those of procedural stress and general anesthesia requires further investigation.
Collapse
Affiliation(s)
- Kaley A Hogarth
- Program in Molecular Medicine, SickKids Research Institute, Toronto, ON, Canada.
- Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
| | - Nicholas A Shkumat
- Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, ON, Canada
- Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
| | - Simal Goman
- Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, ON, Canada
| | - Afsaneh Amirabadi
- Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, ON, Canada
| | - Suzanne Bickford
- Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, ON, Canada
- Paediatric Neurovascular Program, The Hospital for Sick Children, Toronto, ON, Canada
| | - Prakash Muthusami
- Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, ON, Canada
- Department of Medical Imaging, University of Toronto, Toronto, ON, Canada
- Paediatric Neurovascular Program, The Hospital for Sick Children, Toronto, ON, Canada
| | - Bairbre L Connolly
- Department of Diagnostic and Interventional Radiology, The Hospital for Sick Children, Toronto, ON, Canada.
- Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.
- Medical Imaging, Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
| | - Jason T Maynes
- Program in Molecular Medicine, SickKids Research Institute, Toronto, ON, Canada.
- Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, 555 University Ave, Toronto, ON, M5G 1X8, Canada.
- Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON, Canada.
- Department of Biochemistry, University of Toronto, Toronto, ON, Canada.
| |
Collapse
|
2
|
Jafarpour SM, Shekarchi B, Bagheri H, Farhood B. The Radioprotective Effects of Melatonin and Nanoselenium on DNA Double-Strand Breaks in Peripheral Lymphocytes Caused by I-131. Indian J Nucl Med 2021; 36:134-139. [PMID: 34385783 PMCID: PMC8320833 DOI: 10.4103/ijnm.ijnm_179_20] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 08/28/2020] [Accepted: 10/03/2020] [Indexed: 12/30/2022] Open
Abstract
Background: One of the treatment modalities for thyroid cancer and hyperthyroidism is radioiodine-131 (I-131) therapy. The use of this therapeutic modality is not completely safe and can lead to oxidative stress, eventually DNA damages. However, these radiation-induced damages can be reduced by antioxidants. This study aimed to investigate the potential radioprotective effects of melatonin and selenium nanoparticles (SeNPs) on DNA double-stranded breaks (DSBs) caused by I-131. Materials and Methods: After obtaining informed consent, 6 ml blood was taken from each volunteer. The samples were divided into two general groups of control (without I-131) and with I-131. Each group was also divided into three subgroups, including without antioxidant, melatonin, and SeNPs. The samples of control group were incubated for 2 h after adding the antioxidants. The samples of I-131 group were first incubated for 1 h with the antioxidants and then the samples re-incubated for another 1 h after adding the I-131. Then, the samples were prepared for γH2AX assay. Results: The findings showed that after 1 h of incubation with 20 μCi I-131/2 mL, the DSB levels increased by 102.9% in comparison with the control group. In the I-131 group, there were significant reductions of the DSB levels after incubation with melatonin (P < 0.001) and SeNPs (P < 0.001) in comparison with the without antioxidant subgroup. Furthermore, the DSB levels at the melatonin + I-131 and the SeNPs + I-131 subgroups decreased to 38% and 30%, respectively, compared to the I-131 subgroup. Conclusion: According to the obtained findings, it can be concluded that the use of melatonin and SeNPs (as radioprotector agents) can reduce the DSB levels induced by I-131 in peripheral lymphocytes.
Collapse
Affiliation(s)
- Seyed Masoud Jafarpour
- Radiation Sciences Research Center (RSRC), AJA University of Medical Sciences, Tehran, Iran
| | - Babak Shekarchi
- Radiation Sciences Research Center (RSRC), AJA University of Medical Sciences, Tehran, Iran
| | - Hamed Bagheri
- Radiation Sciences Research Center (RSRC), AJA University of Medical Sciences, Tehran, Iran
| | - Bagher Farhood
- Department of Medical Physics and Radiology, Faculty of Paramedicine, Kashan University of Medical Sciences, Kashan, Iran
| |
Collapse
|
3
|
Kaatsch HL, Becker BV, Schüle S, Ostheim P, Nestler K, Jakobi J, Schäfer B, Hantke T, Brockmann MA, Abend M, Waldeck S, Port M, Scherthan H, Ullmann R. Gene expression changes and DNA damage after ex vivo exposure of peripheral blood cells to various CT photon spectra. Sci Rep 2021; 11:12060. [PMID: 34103547 PMCID: PMC8187728 DOI: 10.1038/s41598-021-91023-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2020] [Accepted: 05/13/2021] [Indexed: 11/09/2022] Open
Abstract
Dual-energy CT provides enhanced diagnostic power with similar or even reduced radiation dose as compared to single-energy CT. Its principle is based on the distinct physical properties of low and high energetic photons, which, however, may also affect the biological effectiveness and hence the extent of CT-induced cellular damage. Therefore, a comparative analysis of biological effectiveness of dual- and single-energy CT scans with focus on early gene regulation and frequency of radiation-induced DNA double strand breaks (DSBs) was performed. Blood samples from three healthy individuals were irradiated ex vivo with single-energy (80 kV and 150 kV) and dual-energy tube voltages (80 kV/Sn150kV) employing a modern dual source CT scanner resulting in Volume Computed Tomography Dose Index (CTDIvol) of 15.79-18.26 mGy and dose length product (DLP) of 606.7-613.8 mGy*cm. Non-irradiated samples served as a control. Differential gene expression in peripheral blood mononuclear cells was analyzed 6 h after irradiation using whole transcriptome sequencing. DSB frequency was studied by 53BP1 + γH2AX co-immunostaining and microscopic evaluation of their focal accumulation at DSBs. Neither the analysis of gene expression nor DSB frequency provided any evidence for significantly increased biological effectiveness of dual-energy CT in comparison to samples irradiated with particular single-energy CT spectra. Relative to control, irradiated samples were characterized by a significantly higher rate of DSBs (p < 0.001) and the shared upregulation of five genes, AEN, BAX, DDB2, FDXR and EDA2R, which have already been suggested as radiation-induced biomarkers in previous studies. Despite steadily decreasing doses, CT diagnostics remain a genotoxic stressor with impact on gene regulation and DNA integrity. However, no evidence was found that varying X-ray spectra of CT impact the extent of cellular damage.
Collapse
Affiliation(s)
- Hanns Leonhard Kaatsch
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Benjamin Valentin Becker
- Department of Radiology, Bundeswehr Central Hospital Koblenz, Rübenacher Straße 170, 56072, Koblenz, Germany.
| | - Simone Schüle
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Patrick Ostheim
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Kai Nestler
- Department of Radiology, Bundeswehr Central Hospital Koblenz, Rübenacher Straße 170, 56072, Koblenz, Germany
| | - Julia Jakobi
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Barbara Schäfer
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Thomas Hantke
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Marc A Brockmann
- Department of Neuroradiology, University Medical Center Mainz, Langenbeckstrasse 1, 55101, Mainz, Germany
| | - Michael Abend
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Stephan Waldeck
- Department of Radiology, Bundeswehr Central Hospital Koblenz, Rübenacher Straße 170, 56072, Koblenz, Germany
| | - Matthias Port
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Harry Scherthan
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany
| | - Reinhard Ullmann
- Bundeswehr Institute of Radiobiology Affiliated to Ulm University, Neuherbergstrasse 11, 80937, Munich, Germany.
| |
Collapse
|